173 related articles for article (PubMed ID: 19597109)
1. Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2.
Goyal S; Chauhan SK; Zhang Q; Dana R
Arch Ophthalmol; 2009 Jul; 127(7):882-7. PubMed ID: 19597109
[TBL] [Abstract][Full Text] [Related]
2. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.
Ecoiffier T; El Annan J; Rashid S; Schaumberg D; Dana R
Arch Ophthalmol; 2008 Dec; 126(12):1695-9. PubMed ID: 19064851
[TBL] [Abstract][Full Text] [Related]
3. Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Rashid S; Jin Y; Ecoiffier T; Barabino S; Schaumberg DA; Dana MR
Arch Ophthalmol; 2008 Feb; 126(2):219-25. PubMed ID: 18268213
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.
Okanobo A; Chauhan SK; Dastjerdi MH; Kodati S; Dana R
Am J Ophthalmol; 2012 Jul; 154(1):63-71. PubMed ID: 22541929
[TBL] [Abstract][Full Text] [Related]
5. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Goyal S; Chauhan SK; Dana R
Arch Ophthalmol; 2012 Jan; 130(1):84-9. PubMed ID: 21911653
[TBL] [Abstract][Full Text] [Related]
6. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
7. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Lee HS; Chauhan SK; Okanobo A; Nallasamy N; Dana R
Cornea; 2011 Dec; 30(12):1465-72. PubMed ID: 21993466
[TBL] [Abstract][Full Text] [Related]
9. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity.
Stevenson W; Sadrai Z; Hua J; Kodati S; Huang JF; Chauhan SK; Dana R
Cornea; 2014 Feb; 33(2):177-83. PubMed ID: 24342887
[TBL] [Abstract][Full Text] [Related]
11. PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease.
Sadrai Z; Stevenson W; Okanobo A; Chen Y; Dohlman TH; Hua J; Amparo F; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3584-91. PubMed ID: 22577075
[TBL] [Abstract][Full Text] [Related]
12. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical azithromycin on corneal innate immune responses.
Sadrai Z; Hajrasouliha AR; Chauhan S; Saban DR; Dastjerdi MH; Dana R
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2525-31. PubMed ID: 21296809
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of topical infliximab in a mouse model of experimental dry eye.
Li Z; Choi W; Oh HJ; Yoon KC
Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030
[TBL] [Abstract][Full Text] [Related]
15. Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
Krauss AH; Corrales RM; Pelegrino FS; Tukler-Henriksson J; Pflugfelder SC; de Paiva CS
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5888-95. PubMed ID: 26348638
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
Qu M; Qi X; Wang Q; Wan L; Li J; Li W; Li Y; Zhou Q
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3776-3785. PubMed ID: 31503282
[TBL] [Abstract][Full Text] [Related]
17. Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities.
Ji YW; Seo Y; Choi W; Yeo A; Noh H; Kim EK; Lee HK
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6829-38. PubMed ID: 25257053
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation.
El Annan J; Goyal S; Zhang Q; Freeman GJ; Sharpe AH; Dana R
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3418-23. PubMed ID: 20019373
[TBL] [Abstract][Full Text] [Related]
19. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
